Video: IMBRUVICA (ibrutinib) in Combination With Rituximab for Waldenstrom’s Macroglobulinemia The following link is to the Cancer Therapy Advisor website featuring the following video IMBRUVICA (ibrutinib) in Combination With Rituximab for Waldenstrom’s Macroglobulinemia Meletios Dimopoulos, MD, discusses his findings at the ASCO 2018 meeting in Chicago. Full link: https://www.cancertherapyadvisor.com/asco-2018/imbruvica-ibrutinib-combination-rituximab-waldenstrom-macroglobulinemia/article/770910/